Dr. Reddys Laboratories Ltd.

The sales surged to Rs. 78095.00 millions, up 33.70% for the June 2025 quarter as against Rs. 58412.00 millions during the corresponding quarter previous year.The Total revenue for the quarter ended June 2025 of  Rs. 29612.00  millions  grew by 108.95% from Rs. 14172.00 millions.OP of the company witnessed a marginal growth to 42353.00 millions from 21708.00 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202506	202406	% Var	202506	202406	% Var	202503	202403	% Var
Sales	78095.00	58412.00	33.70	78095.00	58412.00	33.70	231154.00	194838.00	18.64
Other Income	3983.00	2178.00	82.87	3983.00	2178.00	82.87	10034.00	8623.00	16.36
PBIDT	42353.00	21708.00	95.10	42353.00	21708.00	95.10	83852.00	67887.00	23.52
Interest	192.00	71.00	170.42	192.00	71.00	170.42	1099.00	218.00	404.13
PBDT	42161.00	21637.00	94.86	42161.00	21637.00	94.86	82753.00	67669.00	22.29
Depreciation	2798.00	2498.00	12.01	2798.00	2498.00	12.01	10394.00	9756.00	6.54
PBT	39363.00	19139.00	105.67	39363.00	19139.00	105.67	72359.00	57913.00	24.94
TAX	9751.00	4967.00	96.32	9751.00	4967.00	96.32	18865.00	14493.00	30.17
Deferred Tax	334.00	301.00	10.96	334.00	301.00	10.96	960.00	875.00	9.71
PAT	29612.00	14172.00	108.95	29612.00	14172.00	108.95	53494.00	43420.00	23.20
Equity	835.00	834.00	0.12	835.00	834.00	0.12	834.00	834.00	0.00
PBIDTM(%)	54.23	37.16	45.93	54.23	37.16	45.93	36.28	34.84	4.11